We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

204 hedge funds and large institutions have $1.04B invested in Natus Medical Inc in 2014 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 73 increasing their positions, 69 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 15

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

22% more capital invested

Capital invested by funds: $848M → $1.04B (+$190M)

11% more funds holding

Funds holding: 184204 (+20)

6% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 69

2% less call options, than puts

Call options by funds: $2.81M | Put options by funds: $2.87M

Holders
204
Holders Change
+20
Holders Change %
+10.87%
% of All Funds
5.44%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
38
Increased
73
Reduced
69
Closed
15
Calls
$2.81M
Puts
$2.87M
Net Calls
-$59K
Net Calls Change
-$8.59M
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
101
Argentus Capital Management
Texas
$1.21M +$140K +4,179 +14%
DIA
102
Dana Investment Advisors
Wisconsin
$1.18M +$1.1M +32,843 New
PCM
103
Price Capital Management
Louisiana
$1.18M +$1.1M +32,607 New
NFA
104
Nationwide Fund Advisors
Ohio
$1.14M -$11.2K -333 -1%
CS
105
Credit Suisse
Switzerland
$1.14M -$400K -11,918 -27%
DII
106
Domini Impact Investments
New York
$1.1M +$229K +6,805 +29%
GCP
107
GSA Capital Partners
United Kingdom
$1.08M +$336K +9,994 +50%
TPSF
108
Texas Permanent School Fund
Texas
$1.06M
CC
109
Curian Capital
Colorado
$1.05M +$383K +11,416 +64%
JP Morgan Chase
110
JP Morgan Chase
New York
$1.02M +$171K +5,105 +22%
MAM
111
Martingale Asset Management
Massachusetts
$1.02M +$385K +11,459 +69%
SO
112
STRS Ohio
Ohio
$1M -$97.4K -2,900 -9%
Bank of America
113
Bank of America
North Carolina
$987K +$502K +14,932 +120%
MLICM
114
Metropolitan Life Insurance Company (MetLife)
New York
$937K
SSWM
115
Sheets Smith Wealth Management
North Carolina
$929K +$866K +25,774 New
P
116
Pitcairn
Pennsylvania
$909K -$200K -5,939 -19%
State of Tennessee, Department of Treasury
117
State of Tennessee, Department of Treasury
Tennessee
$908K -$94.1K -2,800 -10%
OSAM
118
O'Shaughnessy Asset Management
Connecticut
$867K +$812K +24,174 New
UFF
119
USA Financial Formulas
Michigan
$866K +$807K +24,029 New
AIG
120
American International Group
New York
$865K -$23.3K -693 -3%
BG
121
BlackRock Group
United Kingdom
$865K +$208K +6,181 +35%
SCA
122
Secor Capital Advisors
New York
$859K +$801K +23,844 New
SGAM
123
Smith Group Asset Management
Texas
$850K +$792K +23,590 New
HI
124
HBK Investments
Texas
$848K -$358K -10,663 -31%
COPPSERS
125
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$830K +$212K +6,320 +38%

NTUS Hedge Fund Activity: Q4 2014 in Review

204 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q4 2014, worth a combined $1.04B — up 22% from $848M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new NTUS positions and 15 closed out — a net gain of 23 holders — while 73 added to existing stakes and 69 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $14.2M. The largest seller was Corsair Capital Management, exiting entirely with an estimated $27.1M sold.

  • 204 institutional investors held Natus Medical Inc (NTUS) as of Q4 2014, up from 184 in Q3 2014.
  • Funds reported $1.04B of Natus Medical Inc stock for Q4 2014, up 22% quarter-over-quarter.
  • 38 funds opened new Natus Medical Inc positions in Q4 2014 and 15 closed out, a net change of +23 holders.
  • The largest Natus Medical Inc buyer in Q4 2014 was Eagle Asset Management, an estimated $14.2M added.
  • The largest Natus Medical Inc seller in Q4 2014 was Corsair Capital Management, an estimated $27.1M sold.

Based on aggregated 13F filings for Q4 2014.